Stefan Pöhlmann
Impact in
- Infectious Diseases top 0.01%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral Infections and Outbreaks Research
- Virology top 0.2%
- HIV Research and Treatment
Papers in
-
- SARS-CoV-2 and COVID-19 Research 152
- Viral Infections and Outbreaks Research 30
- Virology 56
- HIV Research and Treatment 56
- Co-authors
- Markus Hoffmann (120 shared papers)Hannah Kleine‐Weber (12 shared papers)Christian Drosten (19 shared papers)Marcel A. Müller (12 shared papers)Nadine Krüger (22 shared papers)Simon Schroeder (4 shared papers)Georg Herrler (4 shared papers)Andreas Nitsche (1 shared paper)
- Journals
- Journal of Virology (44 papers)Virology (20 papers)PLoS ONE (19 papers)The Lancet Infectious Diseases (17 papers)Viruses (15 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Stefan Pöhlmann
293 papers receiving 38.1k citations
Stefan Pöhlmann's Hit Papers
Peers
Comparison fields: 5 of 166
- Infectious Diseases 25.5k
- Virology 2.2k
- General Dentistry 141
- Immunology 2.3k
- Computational Theory and Mathematics 1.3k
Countries citing papers authored by Stefan Pöhlmann
This map shows the geographic impact of Stefan Pöhlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Pöhlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Pöhlmann more than expected).
Fields of papers citing papers by Stefan Pöhlmann
This network shows the impact of papers produced by Stefan Pöhlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Pöhlmann. The network helps show where Stefan Pöhlmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Pöhlmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 305 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Hit paper breakdown → | 2020 | 15563 |
| 2 | A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells Hit paper breakdown → | 2020 | 1409 |
| 3 | Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response Hit paper breakdown → | 2011 | 867 |
| 4 | SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies Hit paper breakdown → | 2021 | 719 |
| 5 | The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic Hit paper breakdown → | 2021 | 711 |
| 6 | TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Hit paper breakdown → | 2013 | 706 |
| 7 | Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry Hit paper breakdown → | 2005 | 652 |
| 8 | 2020 | 500 | |
| 9 | Protease inhibitors targeting coronavirus and filovirus entry Hit paper breakdown → | 2015 | 471 |
| 10 | 2002 | 443 | |
| 11 | Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 Hit paper breakdown → | 2009 | 414 |
| 12 | 2020 | 395 | |
| 13 | 2002 | 362 | |
| 14 | 2011 | 350 | |
| 15 | Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination Hit paper breakdown → | 2021 | 347 |
| 16 | 2020 | 346 | |
| 17 | 2012 | 336 | |
| 18 | 2004 | 329 | |
| 19 | 2013 | 329 | |
| 20 | 2003 | 328 |
About Stefan Pöhlmann
Stefan Pöhlmann is a scholar working on Infectious Diseases, Virology, Epidemiology, Immunology and Molecular Biology, having authored 305 papers that have together received 39.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (152 papers), HIV Research and Treatment (56 papers), Viral Infections and Outbreaks Research (30 papers), Influenza Virus Research Studies (27 papers), interferon and immune responses (17 papers), Glycosylation and Glycoproteins Research (14 papers), Virology and Viral Diseases (8 papers) and Carbohydrate Chemistry and Synthesis (7 papers). The work is most often cited by research in Infectious Diseases (25.5k citations), Virology (2.2k citations), General Dentistry (141 citations), Immunology (2.3k citations) and Computational Theory and Mathematics (1.3k citations). Stefan Pöhlmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Markus Hoffmann, Hannah Kleine‐Weber, Christian Drosten, Marcel A. Müller, Nadine Krüger, Simon Schroeder, Georg Herrler, Andreas Nitsche, Nai‐Huei Wu and Tanja Herrler. Their work appears in journals such as Journal of Virology, Virology, PLoS ONE, The Lancet Infectious Diseases and Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.